Profound Medical (PROF) Retained Earnings (2018 - 2026)
Profound Medical's (PROF) quarterly Retained Earnings came in at -$294.8 million in Q1 2026, down 15.2% year-on-year from -$347.6 million in Q1 2025, and down 1264.73% quarter-over-quarter from $25.3 million in Q4 2025.
Profound Medical (PROF) Retained Earnings (2018 - 2026) Analysis & Trends
Profound Medical's Retained Earnings history runs 9 years deep, the most recent figure standing at -$294.8 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 15.2% year-over-year to -$294.8 million in Q1 2026; TTM through Mar 2026 was -$294.8 million, a 15.2% decrease from a year earlier, with the FY2025 full-year figure at $25.3 million, up 823.05% from the prior year.
- Retained Earnings fell to -$294.8 million in Q1 2026 per PROF's latest filing, from $25.3 million in the prior quarter.
- Across five years, Retained Earnings topped out at $25.3 million in Q4 2025 and bottomed at -$294.8 million in Q1 2026.
- The 5-year median for Retained Earnings is $4.1 million (2024), against an average of -$82.7 million.
- Across the five-year window, Retained Earnings tumbled 1214.81% in 2022 and surged 823.05% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$189.4 million in 2022, then soared by 110.99% to $20.8 million in 2023, then plunged by 86.82% to $2.7 million in 2024, then jumped by 823.05% to $25.3 million in 2025, then sank by 1264.73% to -$294.8 million in 2026.
- Per Business Quant, the three latest PROF Retained Earnings figures stand at -$294.8 million (Q1 2026), $25.3 million (Q4 2025), and $24.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Profound Medical | 248.64 Mn | 198.34 Mn | 3.83 Mn | -294.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -294.79 Mn |
| Dec 31, 2025 | 25.31 Mn |
| Sep 30, 2025 | 24.21 Mn |
| Jun 30, 2025 | 5.56 Mn |
| Mar 31, 2025 | -255.89 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Dec 31, 2023 | 20.81 Mn |
| Dec 31, 2022 | -189.36 Mn |
| Dec 31, 2021 | 16.99 Mn |
| Dec 31, 2020 | -129.99 Mn |
| Dec 31, 2019 | 14.83 Mn |
| Jan 1, 2019 | 12.28 Mn |
| Dec 31, 2018 | -84.12 Mn |